Skip to main content

New Vaccine Development: Establishing Priorities: Volume I: Diseases of Importance in the United States

View Cover

New Vaccine Development

Establishing Priorities: Volume I: Diseases of Importance in the United States (1985)
Overview

Contributors

Topics

Suggested Citation

Institute of Medicine. 1985. New Vaccine Development: Establishing Priorities: Volume I: Diseases of Importance in the United States. Washington, DC: The National Academies Press. https://doi.org/10.17226/12085.

Import this citation to:

Publication Info

472 pages | 6 x 9
DOI: https://doi.org/10.17226/12085
Contents

Table of Contents

skim chapter
Front Matter i-xiv
1. Summary 1-16
2. Priority Setting for Health Related Investments: A Review of Methods 17-27
3. Overview of the Analytic Approach 28-38
4. Comparison of Disease Burdens and Costs 39-58
5. Predictions on Vaccine Development 59-66
6. Assessing the Likely Utilization of New Vaccines 67-91
7. Calculation and Comparison of the Health Benefits and Costs Associated with Candidate Vaccines 92-120
8. Additional Issues in the Selection of Priorities for Accelerated Vaccine Development 121-126
9. Findings, Conclusions, and Recommendations 127-148
Appendix A: Some Examples of the Application of Project Selection Method 149-152
Appendix B: Pathogenic Agents for Which Accelerated Vaccine Development Does Not Appear Appropriate 153-170
Appendix C: Prospects for Immunizing Against Bordetella pertussis 171-182
Appendix D: Prospects for Immunizing Against Coccidioidomycosis 183-197
Appendix E: Prospects for Immunizing Against Cytomegalovirus 198-234
Appendix F: Prospects for Immunizing Against Hemophilus influenzae type b 235-251
Appendix G: Prospects for Immunizing Against Hepatitis A Virus 252-260
Appendix H: Prospects for Immunizing Against Hepatitis B Virus 261-279
Appendix I: Prospects for Immunizing Against Herpes Simplex Viruses 1 and 2 280-312
Appendix J: Prospects for Immunizing Against Herpesvirus varicellae 313-341
Appendix K: Prospects for Immunizing Against Influenza Viruses A and B 342-364
Appendix L: Prospects for Immunizing Against Neisseria gonorrhoeae 365-384
Appendix M: Prospects for Immunizing Against Parainfluenza Viruses 385-396
Appendix N: Prospects for Immunizing Against Respiratory Syncytial Virus 397-409
Appendix O: Prospects for Immunizing Against Rotavirus 410-423
Appendix P: Prospects for Immunizing Against Streptococcus group B 424-439
Appendix Q: Questionnaire for Assessing Morbidity-Mortality Trade-Offs 440-443
Appendix R: Technical Notes 444-444
Appendix S: Biographical Notes on Committee Members 445-449
Appendix T: Additional Sources of Advice to the Committee 450-452
Index 453-458
Rights

Copyright Information

The National Academies Press and the Transportation Research Board have partnered with Copyright Clearance Center to offer a variety of options for reusing our content. You may request permission to:

  • Republish or display in another publication, presentation, or other media
  • Use in print or electronic course materials and dissertations
  • Share electronically via secure intranet or extranet
  • And more

For most Academic and Educational uses no royalties will be charged although you are required to obtain a license and comply with the license terms and conditions.

Click here to obtain permission for New Vaccine Development: Establishing Priorities: Volume I: Diseases of Importance in the United States.

Translation and Other Rights

For information on how to request permission to translate our work and for any other rights related query please click here.

Copyright.com Customer Service

For questions about using the Copyright.com service, please contact:

Copyright Clearance Center
22 Rosewood Drive
Danvers, MA 01923
Tel (toll free): 855/239-3415 (select option 1)
E-mail: info@copyright.com
Web: https://www.copyright.com
Stats

Loading stats for New Vaccine Development: Establishing Priorities: Volume I: Diseases of Importance in the United States...